Japan aims to fast-track review of anti-viral drug remdesivir

  • 📰 Reuters
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 97%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Japan will fast-track a review of Gilead Sciences Inc's antiviral drug remdesivir so that it can hopefully be approved for domestic COVID-19 patients a week after the U.S. firm's filing for such approval, the health minister said on Saturday.

FILE PHOTO: Gilead Sciences Inc in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake/File Photo

Health Minister Katsunobu Kato’s comment comes after remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

It's a fraud. It was tried at the beginning of the pandemic and didn't work. This is the second attempt and America is grasping straws. In a few weeks it will be abandoned again.

Ridiculous. This med reduced death rates from 11% to 8% in a single study. The promise of this med is being way overblown.

Great!!

rajeshtope11

and what happens if CoV vaccines have side effects damaging people's (neuro-endocrine) reproductive systems? WHO FDAWomen

Aarrefaafa

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Gilead to work with partners to ramp up production of potential coronavirus treatmentGilead Sciences Inc , maker of the closely-watched experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment. Gilead , Moderna candidates ramp up coronavirus drug ,vaccine testing. Someone is selling their Soul to get that drug approved with the right studies
Source: Reuters - 🏆 2. / 97 Read more »

Gilead says it can produce 'several million' rounds of remdesivir coronavirus treatments next year“We’re just humbled and pleased by the results this week as a starting point for therapies in COVID-19.” Gilead CEO Daniel O’Day discussed the positive results released this week from 2 remdesivir studies. Who’s this pumpkin with the Moave tie on guy lose your stomach and the tie Jiving Joe and his Trump Humpers.
Source: CNBC - 🏆 12. / 72 Read more »